{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:33:16Z","timestamp":1764081196001,"version":"3.45.0"},"reference-count":8,"publisher":"Massachusetts Medical Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEJM Evidence"],"published-print":{"date-parts":[[2025,11,25]]},"DOI":"10.1056\/evide2500282","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:00:09Z","timestamp":1762380009000},"source":"Crossref","is-referenced-by-count":0,"title":["Oral Psoriasis Therapy \u2014 For Whom and at What Cost and Risk?"],"prefix":"10.1056","volume":"4","author":[{"given":"Robert S.","family":"Stern","sequence":"first","affiliation":[{"name":"Department of Dermatology, Harvard Medical School, Boston"},{"name":"Department of Dermatology, Beth Israel Deaconess Medical Center, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"150","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2007"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011535.pub5"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308713"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2504187"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2500155"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119669"},{"key":"e_1_3_3_9_2","unstructured":"Fortune Business Insights. Psoriasis treatment market size share & industry analysis by drug class (TNF inhibitors interleukins inhibitors and others) by type (plaque psoriasis psoriatic arthritis and others) by product type (biologics and non-biologics) by route of administration (oral parenteral\/systemic and topical) by distribution channel (hospital pharmacies retail pharmacies and online pharmacies) and regional forecast 2025\u20132032. September 29 2025 (https:\/\/www.fortunebusinessinsights.com\/industry-reports\/psoriasis-treatment-market-100600)."}],"container-title":["NEJM Evidence"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:30:38Z","timestamp":1764081038000},"score":1,"resource":{"primary":{"URL":"https:\/\/evidence.nejm.org\/doi\/10.1056\/EVIDe2500282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,11,25]]}},"alternative-id":["10.1056\/EVIDe2500282"],"URL":"https:\/\/doi.org\/10.1056\/evide2500282","relation":{},"ISSN":["2766-5526"],"issn-type":[{"type":"print","value":"2766-5526"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}